July 2023
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference focused on the way forward for the safe and effective use of artificial intelligence in healthcare.
It was a timely opportunity to examine the MHRA’s Software and AI as a Medical Device programme and regulatory framework, which was due for implementation in July 2023.
The discussion also came with a range of wider policy developments including the publication of the A pro-innovation approach to AI regulation white paper, as well as the National AI Strategy, and government initiatives on use of data and digital technologies in healthcare.
Key stakeholders and policymakers assessed challenges for healthcare workers using AI technologies, developing workforce confidence in AI, and involving clinicians in the development of new technologies in the context of the publication of Health Education England’s Developing Healthcare Workers’ Confidence in AI report.
Further sessions looked at:
- the next steps for research, development and implementation of AI in health and social care, and how it can address current and future challenges in healthcare
- opportunities for use of AI to address current clinical challenges including efficiency savings, early diagnosis, waiting times and care backlogs, and health inequalities
- prospects for the UK’s potential leadership in the development and regulation of health and care-related AI
We are pleased to have been able to include keynote sessions with Dominic Cushnan, Director of AI, Imaging and Deployment, NHS England; Clíodhna Ní Ghuidhir, Principal Scientific Adviser for AI, National Institute for Health and Care Excellence; Dr Hatim Abdulhussein, Clinical Fellow, AI and Robotics, and Clinical Lead, Health Education England; Dr Paul Campbell, Senior Clinical Assessor, Software, Medicines and Healthcare products Regulatory Agency; and Dr Russ Pearson, AI Policy Specialist, Medicines and Healthcare products Regulatory Agency.
Overall, sessions in the agenda included:
- the health and social care AI landscape: current use and the future potential of AI in health and social care
- safe and effective use: priority areas for improving outcomes for patients and efficiencies - R&D - investment - support and training for staff - patient trust and engagement
- regulation:
- software and AI roadmap implementation - clarity and guidance for industry - cooperation - agility to keep pace with future developments
- ensuring patient safety - cybersecurity - data protection - accountability and governance
- workforce: priorities for supporting workforce skills and confidence in AI-based technologies - clinician involvement in the development process and building clinician trust
- R&D: priorities for innovation in AI - next steps for optimising its use in healthcare - developing the use of real-world evidence
- policy: the future for harnessing the potential of AI in healthcare - safe delivery - sector growth - opportunities of UK leadership in AI-powered healthcare and regulation
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from the CQC; Department for Education, NI; Department for the Economy, NI; Department of Health, ROI; DHSC; DSIT; FCDO; HMRC; HSE; ICO; IPO; MHRA; NAO; OLS; UKHSA; UKSA; The Scottish Government; and the Welsh Government.
